Michael L. Babich is President at Insys Therapeutics, Inc. (INSY). They have made 3 open-market trades across 1 company since 2013, most recently 2015-09-22.
CIK 0001368078
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $39K since 2013, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INSY | 421,572 | $123K |
Shares reported on the most recent Form 4, priced at the 2015-09-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INSY | SELL · 10b5-1 | 2015-03-16 | 2015-03-18 | $58.63 | $4.4M | -17.2% | -0.9% | -0.9% |
| INSY | SELL · 10b5-1 | 2014-11-03 | 2014-11-04 | $38.66 | $3.1M | -17.2% | -0.9% | -0.9% |
| INSY | SELL · 10b5-1 | 2014-10-21 | 2014-10-22 | $40.17 | $803K | -17.2% | -0.9% | -0.9% |
| INSY | SELL | 2014-03-05 | 2014-03-06 | $74.58 | $21.5M | -17.2% | -0.9% | -0.9% |
| INSY | BUY | 2013-08-16 | 2013-08-16 | $24.90 | $25K | -17.2% | -0.9% | -0.9% |
| INSY | BUY | 2013-06-04 | 2013-06-04 | $10.93 | $14K | -17.2% | -0.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.